Receptor may hold key to multiple sclerosis treatment

(Medical Xpress) -- A receptor (the A2A adenosine receptor) recently discovered to control the movement of immune cells across central nervous system barriers (including the blood-brain barrier) may hold the key to treating multiple sclerosis (MS), a neuroinflammatory disease of the central nervous system.